(Q37862752)

24 August 2017

1 reference

title

Soluble markers for diagnosis of malignant pleural mesothelioma (English)

1 reference

24 August 2017

0 references

5

Rudy Foddis

1 reference

24 August 2017

1

Alfonso Cristaudo

1 reference

24 August 2017

2

Alessandra Bonotti

1 reference

24 August 2017

Silvia Simonini

3

1 reference

24 August 2017

Rossella Bruno

series ordinal

4

1 reference

24 August 2017

publication date

1 April 2011

1 reference

24 August 2017

published in

Biomarkers in Medicine

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

261-273

1 reference

Malignant mesothelioma: attributable risk of asbestos exposure.

24 August 2017

cites work

1 reference

Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey

21 January 2018

1 reference

The European mesothelioma epidemic

21 January 2018

1 reference

Projection of mesothelioma mortality in Britain using Bayesian methods

21 January 2018

1 reference

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

21 January 2018

1 reference

Survival of pleural malignant mesothelioma in Italy: a population-based study

21 January 2018

1 reference

Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma

21 January 2018

1 reference

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

21 January 2018

1 reference

Multimodality strategies in malignant pleural mesothelioma

21 January 2018

1 reference

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

21 January 2018

1 reference

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

21 January 2018

1 reference

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.

21 January 2018

1 reference

Malignant pleural mesothelioma: an update on biomarkers and treatment

21 January 2018

1 reference

The role of PET in the surgical management of malignant pleural mesothelioma

21 January 2018

1 reference

Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.

21 January 2018

1 reference

Mesothelin: a new target for immunotherapy

21 January 2018

1 reference

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

21 January 2018

1 reference

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

21 January 2018

1 reference

MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus

21 January 2018

1 reference

The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma

21 January 2018

1 reference

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

21 January 2018

1 reference

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

21 January 2018

1 reference

Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells

21 January 2018

1 reference

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

21 January 2018

1 reference

MESOMARK: a potential test for malignant pleural mesothelioma

21 January 2018

1 reference

Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.

21 January 2018

1 reference

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer

21 January 2018

1 reference

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

21 January 2018

1 reference

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein

21 January 2018

1 reference

Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population

21 January 2018

1 reference

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum

21 January 2018

1 reference

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer

21 January 2018

1 reference

Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis

21 January 2018

1 reference

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

21 January 2018

1 reference

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions

21 January 2018

1 reference

Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.

21 January 2018

1 reference

Characterization, molecular cloning and expression of megakaryocyte potentiating factor

21 January 2018

1 reference

Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers

21 January 2018

1 reference

Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma

21 January 2018

1 reference

Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin

21 January 2018

1 reference

Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma

21 January 2018

1 reference

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

21 January 2018

1 reference

Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence

21 January 2018

1 reference

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

Transformed mammalian cells secrete specific proteins and phosphoproteins

21 January 2018

1 reference

Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels

21 January 2018

1 reference

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.

21 January 2018

1 reference

Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.

21 January 2018

1 reference

Plasma osteopontin levels in multiple sclerosis.

21 January 2018

1 reference

Tumorigenic properties of alternative osteopontin isoforms in mesothelioma

21 January 2018

1 reference

Role of osteopontin in tumour progression

21 January 2018

1 reference

The role of Osteopontin in tumor metastasis

21 January 2018

1 reference

Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.

21 January 2018

1 reference

Osteopontin levels in an asbestos-exposed population

21 January 2018

1 reference

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions

21 January 2018

1 reference

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

21 January 2018

1 reference

MUC1 and colorectal cancer pathophysiology considerations

21 January 2018

1 reference

Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.

21 January 2018

1 reference

The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type

21 January 2018

1 reference

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients

21 January 2018

1 reference

Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis

21 January 2018

1 reference

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion

21 January 2018

1 reference

Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).

21 January 2018

1 reference

Expression of human mammaglobin gene in pleural effusions of patients with malignant mesothelioma

21 January 2018

1 reference

Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.

21 January 2018

1 reference

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

21 January 2018

1 reference

Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma

21 January 2018

1 reference

Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma

21 January 2018

1 reference

Serum hyaluronan as a disease marker

21 January 2018

1 reference

Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization

21 January 2018

1 reference

Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.

21 January 2018

1 reference

Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study

21 January 2018

1 reference

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma

21 January 2018

1 reference

Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma

21 January 2018

1 reference

Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

21 January 2018

1 reference

Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment

21 January 2018

1 reference

Complex Cytokeratin Polypeptide Patterns Observed in Certain Human Carcinomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.11.18

1 reference

24 August 2017

1 reference